Boostrix Lawsuit
If the Boostrix® Tdap vaccine resulted in you or your child suffering from a Shoulder Injury Related to Vaccine Administration (SIRVA), your may be entitled to $250,000 from the Vaccine...
-
-
Meningococcal Vaccine Lawsuit
If the meningococcal vaccine caused you or your child to develop a Shoulder Injury Related to Vaccine Administration (SIRVA), you could receive up to $250,000 from the Vaccine Injury Compensation...
-
Afluria Lawsuit
If the flu vaccine Afluria caused you or your child to develop Guillain-Barré Syndrome (GBS) or a Shoulder Injury Related to Vaccine Administration (SIRVA), your may be entitled to up...
-
Adacel Lawsuit
You or your child may be entitled to up to $250,000 from the Vaccine Injury Compensation Program if the Adacel vaccine caused a Shoulder Injury Related to Vaccine Administration (SIRVA)....
-
ActHIB Lawsuit
If your child developed a Shoulder Injury Related to Vaccine Administration (SIRVA) after receiving an ActHIB vaccine, you may be entitled to up to $250,000 from the Vaccine Injury Compensation...
-
Guillain-Barré Syndrome
What is Guillain-Barré Syndrome? Guillain-Barré Syndrome (GBS) occurs when the immune system malfunctions and attacks the body’s own nerves — specifically the peripheral nerves, which are the nerves that connect...
-
Shoulder Injury Related to Vaccine Administration (SIRVA)
What is SIRVA? Shoulder Injury Related to Vaccine Administration (SIRVA) causes intense, prolonged shoulder pain, with limited range of motion, and sometimes shoulder damage that requires surgery. SIRVA involves painful...
-
Thousands of Cheerleaders Exposed to Mumps in Texas
Thousands of cheerleaders who attended a national competition last month in Texas may have been exposed to mumps. On March 2, officials at the Texas Department of State Health Services...
-
2017-2018 Flu Season Show Signs of Slowing Down
The most severe flu outbreak in the U.S. in decades is finally showing signs of slowing down, according to an update from the U.S. Centers for Disease Control and Prevention...
-
FluMist Nasal Flu Vaccine May Return Next Season
After 2 years off the market due to ineffectiveness, the FluMist® nasal flu vaccine is set to return to doctors’ offices next year — but will it work better than...